DK3638680T3 - Heteroaromatiske forbindelser som vanininhibitorer - Google Patents
Heteroaromatiske forbindelser som vanininhibitorer Download PDFInfo
- Publication number
- DK3638680T3 DK3638680T3 DK18731766.4T DK18731766T DK3638680T3 DK 3638680 T3 DK3638680 T3 DK 3638680T3 DK 18731766 T DK18731766 T DK 18731766T DK 3638680 T3 DK3638680 T3 DK 3638680T3
- Authority
- DK
- Denmark
- Prior art keywords
- heteroaromatic compounds
- vanin
- inhibitors
- vanin inhibitors
- heteroaromatic
- Prior art date
Links
- 150000002390 heteroarenes Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762518106P | 2017-06-12 | 2017-06-12 | |
| PCT/EP2018/065140 WO2018228934A1 (en) | 2017-06-12 | 2018-06-08 | Heteroaromatic compounds as vanin inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3638680T3 true DK3638680T3 (da) | 2022-09-05 |
Family
ID=62631060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18731766.4T DK3638680T3 (da) | 2017-06-12 | 2018-06-08 | Heteroaromatiske forbindelser som vanininhibitorer |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US10364255B2 (da) |
| EP (1) | EP3638680B1 (da) |
| JP (1) | JP6880243B2 (da) |
| KR (1) | KR102607934B1 (da) |
| CN (1) | CN110770242B (da) |
| AR (1) | AR112086A1 (da) |
| AU (1) | AU2018285131B2 (da) |
| CA (1) | CA3066946A1 (da) |
| CL (1) | CL2019003515A1 (da) |
| CO (1) | CO2019013823A2 (da) |
| DK (1) | DK3638680T3 (da) |
| EA (1) | EA039223B1 (da) |
| ES (1) | ES2927021T3 (da) |
| HU (1) | HUE060597T2 (da) |
| IL (1) | IL271104B (da) |
| MA (1) | MA49374A (da) |
| MX (1) | MX394645B (da) |
| PE (1) | PE20200340A1 (da) |
| PH (1) | PH12019502693A1 (da) |
| PL (1) | PL3638680T3 (da) |
| TW (1) | TWI855993B (da) |
| WO (1) | WO2018228934A1 (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3824906A1 (en) | 2016-12-21 | 2021-05-26 | Amgen Inc. | Anti-tnf alpha antibody formulations |
| PE20200340A1 (es) * | 2017-06-12 | 2020-02-14 | Boehringer Ingelheim Int | Compuestos heteroaromaticos como inhibidores de vanina |
| EP3837263B1 (en) | 2018-08-13 | 2024-07-03 | F. Hoffmann-La Roche AG | New heterocyclic compounds as monoacylglycerol lipase inhibitors |
| JOP20210034A1 (ar) * | 2018-08-28 | 2021-02-25 | Boehringer Ingelheim Int | مركبات عطرية غير متجانسة كمثبطات Vanin |
| EP3883936B1 (en) | 2018-11-22 | 2023-07-12 | F. Hoffmann-La Roche AG | New heterocyclic compounds |
| BR112021007915A2 (pt) | 2018-12-03 | 2021-07-27 | Boehringer Ingelheim International Gmbh | compostos heteroaromáticos utilizados como inibidores de vanina |
| JP7080405B2 (ja) | 2018-12-03 | 2022-06-03 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | バニン阻害剤としての複素芳香族化合物 |
| EA202191478A1 (ru) | 2018-12-03 | 2021-10-26 | Бёрингер Ингельхайм Интернациональ Гмбх | Гетероароматические соединения в качестве ингибиторов ванина |
| US11814375B2 (en) | 2019-09-12 | 2023-11-14 | Hoffmann-La Roche Inc. | Heterocyclic compounds |
| US20230107927A1 (en) | 2020-02-28 | 2023-04-06 | First Wave Bio, Inc. | Methods of treating iatrogenic autoimmune colitis |
| EP4696293A1 (en) | 2023-04-10 | 2026-02-18 | Umov SPA | Rehabilitation and monitoring system |
| CN118892548A (zh) * | 2024-08-12 | 2024-11-05 | 中国人民解放军陆军特色医学中心 | Vanin-1抑制剂在制备治疗急性肾损伤继发急性肺损伤的药物中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602004018811D1 (de) * | 2003-10-09 | 2009-02-12 | Abbott Lab | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren |
| EP3303303A1 (en) * | 2015-05-29 | 2018-04-11 | Pfizer Inc | Novel heterocyclic compounds as inhibitors of vanin-1 enzyme |
| BR112019000589A2 (pt) * | 2016-07-14 | 2019-04-24 | Pfizer Inc. | pirimidina carboxamidas como inibidores da enzima vanina-1 |
| PE20200340A1 (es) * | 2017-06-12 | 2020-02-14 | Boehringer Ingelheim Int | Compuestos heteroaromaticos como inhibidores de vanina |
-
2018
- 2018-06-08 PE PE2019002531A patent/PE20200340A1/es unknown
- 2018-06-08 EA EA202090014A patent/EA039223B1/ru unknown
- 2018-06-08 ES ES18731766T patent/ES2927021T3/es active Active
- 2018-06-08 MX MX2019014876A patent/MX394645B/es unknown
- 2018-06-08 HU HUE18731766A patent/HUE060597T2/hu unknown
- 2018-06-08 PL PL18731766.4T patent/PL3638680T3/pl unknown
- 2018-06-08 US US16/003,252 patent/US10364255B2/en active Active
- 2018-06-08 CA CA3066946A patent/CA3066946A1/en active Pending
- 2018-06-08 WO PCT/EP2018/065140 patent/WO2018228934A1/en not_active Ceased
- 2018-06-08 AU AU2018285131A patent/AU2018285131B2/en active Active
- 2018-06-08 CN CN201880039562.3A patent/CN110770242B/zh active Active
- 2018-06-08 EP EP18731766.4A patent/EP3638680B1/en active Active
- 2018-06-08 JP JP2019566724A patent/JP6880243B2/ja active Active
- 2018-06-08 DK DK18731766.4T patent/DK3638680T3/da active
- 2018-06-08 KR KR1020197038628A patent/KR102607934B1/ko active Active
- 2018-06-08 MA MA049374A patent/MA49374A/fr unknown
- 2018-06-11 TW TW107119946A patent/TWI855993B/zh active
- 2018-06-11 AR ARP180101573A patent/AR112086A1/es unknown
-
2019
- 2019-05-13 US US16/410,037 patent/US20190263828A1/en not_active Abandoned
- 2019-11-28 PH PH12019502693A patent/PH12019502693A1/en unknown
- 2019-12-02 CL CL2019003515A patent/CL2019003515A1/es unknown
- 2019-12-02 IL IL271104A patent/IL271104B/en unknown
- 2019-12-09 CO CONC2019/0013823A patent/CO2019013823A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2020522517A (ja) | 2020-07-30 |
| AU2018285131A1 (en) | 2019-10-31 |
| US10364255B2 (en) | 2019-07-30 |
| IL271104B (en) | 2022-03-01 |
| CL2019003515A1 (es) | 2020-06-19 |
| TW201920196A (zh) | 2019-06-01 |
| AR112086A1 (es) | 2019-09-18 |
| CN110770242B (zh) | 2022-08-19 |
| PL3638680T3 (pl) | 2022-12-19 |
| AU2018285131B2 (en) | 2021-11-11 |
| PH12019502693A1 (en) | 2020-07-13 |
| JP6880243B2 (ja) | 2021-06-02 |
| PE20200340A1 (es) | 2020-02-14 |
| TWI855993B (zh) | 2024-09-21 |
| WO2018228934A1 (en) | 2018-12-20 |
| HUE060597T2 (hu) | 2023-04-28 |
| EP3638680A1 (en) | 2020-04-22 |
| EA202090014A1 (ru) | 2020-05-12 |
| CO2019013823A2 (es) | 2020-01-17 |
| KR102607934B1 (ko) | 2023-12-01 |
| ES2927021T3 (es) | 2022-11-02 |
| KR20200013718A (ko) | 2020-02-07 |
| CA3066946A1 (en) | 2018-12-20 |
| CN110770242A (zh) | 2020-02-07 |
| IL271104A (en) | 2020-01-30 |
| MX394645B (es) | 2025-03-21 |
| MX2019014876A (es) | 2020-02-13 |
| EA039223B1 (ru) | 2021-12-20 |
| US20190263828A1 (en) | 2019-08-29 |
| MA49374A (fr) | 2021-04-21 |
| US20180354968A1 (en) | 2018-12-13 |
| EP3638680B1 (en) | 2022-08-10 |
| BR112019021703A2 (pt) | 2020-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2024003I1 (el) | Ενωσεις χρησιμες ως αναστολεις κινασης | |
| DK3697785T3 (da) | Imidazo-pyridine forbindelser som pad-inhibitorer | |
| DK3728252T3 (da) | 4-azaindolforbindelser | |
| DK3684767T3 (da) | Heterocykliske forbindelser som pad-inhibitorer | |
| DK3638680T3 (da) | Heteroaromatiske forbindelser som vanininhibitorer | |
| DK3442980T3 (da) | Heterocykliske forbindelser som ret-kinase-hæmmere | |
| DK3371190T3 (da) | Heterocykliske forbindelser som pi3k-gamma-inhibitorer | |
| DK3277677T3 (da) | 1-cyano-pyrrolidinforbindelser som usp30-hæmmere | |
| LT3580220T (lt) | Aminotriazolopiridinai, kaip kinazės inhibitoriai | |
| DK3298002T3 (da) | Heterocykliske amider som kinasehæmmere | |
| LT3609898T (lt) | Junginiai, naudingi kaip ret inhibitoriai | |
| DK3294713T3 (da) | Substituerede tetrahydroquinolinonforbindelser som ror-gamma-modulatorer | |
| DK3582780T3 (da) | Aminopyrimidinforbindelser, der er anvendelige som SSAO-inhibitorer | |
| DK3544981T3 (da) | Benzodiazoliumforbindelser som enac-inhibitorer | |
| DK3844161T3 (da) | Heteroaromatiske forbindelser som vanininhibitorer. | |
| DK3592745T3 (da) | Pyrimidopyrimidinoner anvendelige som Wee-1 kinaseinhibitorer | |
| DK3762368T3 (da) | Aminopyrazindiolforbindelser som pi3k-y-inhibitorer | |
| LT3704118T (lt) | Aminoimidazopiridazinai, kaip kinazės inhibitoriai | |
| IL283397A (en) | Heteroaromatic compounds as vanin inhibitors | |
| DK3717488T3 (da) | Substituerede furanopyrimidinforbindelser som pde1-inhibitorer | |
| DK3458460T3 (da) | Imidazoler som histondemethylase-inhibitorer | |
| DK3890828T3 (da) | Heteroaromatiske forbindelser som vanin-hæmmere | |
| DK3700907T3 (da) | Hidtil ukendte pyrazolo-pyrrolo-pyrimidindion-derivater som p2x3-inhibitorer | |
| LT3347360T (lt) | Junginiai, naudingi ror-gama-t slopinimui | |
| DK3319970T3 (da) | Pyrido-oxazinonderivater som tnap-hæmmere |